Kožní a korektivně dermatologické pracoviště
- Address
- Písečná 5549, 430 04 Chomutov, Czechia
Dermatology and Corrective Dermatological Center
This specialized dermatological center focuses on advanced clinical research in chronic inflammatory skin conditions, with particular expertise in plaque psoriasis. The facility participates in pivotal Phase 3 clinical trials evaluating innovative therapeutic approaches for patients suffering from moderate to severe dermatological conditions.
- Moderate to severe plaque psoriasis treatment and management
- Long-term safety and efficacy assessment of novel dermatological therapies
- Advanced clinical trial methodology in chronic skin disorders
The center demonstrates comprehensive capabilities in conducting both randomized controlled trials and extension studies, allowing for thorough evaluation of treatment efficacy, safety profiles, and durability of therapeutic response. Their involvement in the ONWARD clinical trial program reflects their commitment to advancing evidence-based treatment options for patients with challenging dermatological conditions requiring specialized corrective and therapeutic interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kožní a korektivně dermatologické pracoviště
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of ESK-001 in Patients with Moderate to Severe Plaque Psoriasis | Alumis Inc. | Phase III | Not Recruiting | Jan 2025 | Nov 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apremilast | 1 | Unknown | 2025-01-16 | 2025-01-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.